EAS Newsletter August 20, 2024
Education:
Just over a week left until ESC Congress 2024. Be sure to stop by our booth in London!
![](https://eas-society.org/wp-content/uploads/2024/08/ESCCongress2024-600x150-generic-withLogo.jpg)
In addition to our official ESC-EAS joint session and the insightful talks delivered by our members and contributors, we’re excited to announce that we will have a dedicated booth at the ESC Congress 2024 in London!
We invite you to stop by and discover more about our activities and upcoming plans. Our team will be on hand to provide guidance on how you can advance your career with EAS.
Don’t miss this opportunity to engage with us and explore the benefits of being part of our community. See you in London!
Publications:
Helping practitioners to translate the guidelines into patient care. Download The Clinician’s Handbook
![](https://eas-society.org/wp-content/uploads/2023/10/image-2.png)
The Clinician’s Handbook was introduced as a bridge between the formal guidelines and clinical practice, to help practitioners to translate the guidelines into patient care. In the Handbook fourteen different clinical cases are presented, and for each one the authors show how the Guidelines are used in the evaluation of the patient’s cardiovascular risk, and in the recommended treatment options.
Since 2019 a number of new studies have been published, some new lipid-lowering drugs have been accepted by the authorities, and new consensus documents have been published by EAS. It is therefore time to publish an updated version of the Handbook that takes into account these recent developments. The goal of this updated version of The Clinician’s Handbook is to follow up the 2019 Guidelines and to discuss how to apply in modern clinical practice the recent progress in drug development and science.
With a background in the 2019 Guidelines, the new lipid-lowering drugs and recent key publications are now discussed in the Handbook’s introduction. And for each case example, the impact of the new therapeutic options and recent scientific progress on clinical practice is discussed in an author’s comment.
Access The Clinician’s Handbook as an EAS memberSociety:
Apply for the EAS Competitive grant: easy, highly rewarding, and open!
![](https://eas-society.org/wp-content/uploads/2024/04/Call-for-grants-banner-2024-1024x576-1.png)
Submitting an application for an EAS Competitive Grant is both straightforward and valuable. Be sure to apply before the deadline on September 13, 2024 – early applications are encouraged to ensure you have ample time to address any queries or issues.
We often receive questions about the grant process. Here are some key details:
1. Who is eligible to apply?
You can apply for an EAS Competitive Grant if you meet all the following criteria:
- You are an Individual Member of EAS.
- You hold a PhD or MD.
- No more than 5 years have passed since you completed your PhD/MD (with adjustments for parental leave).
- Your workplace confirms that you have the necessary resources, employment or affiliation status, and support to carry out the project.
2. What types of projects are eligible for funding?
EAS is interested in funding research projects that focus on basic research, preclinical studies, and translational research.
If you have any further questions or need additional information, please feel free to contact us. We’re here to assist you throughout the application process!
Apply for Competitive grants for EAS members 2024Education:
Explore the role of TRLs in atherosclerosis: join our third EAS-LatAm webinar!
![](https://eas-society.org/wp-content/uploads/2024/03/LatAm_webinar3-1024x576.png)
There have long been debates regarding the atherogenic role of triglyceride-rich lipoproteins (TRLs) and whether mild or moderate increases should be addressed pharmacologically. While not all the mechanisms explaining the residual risk are known, TRLs are believed to play a significant role. Gaining a better understanding of TRLs’ effects on the atherosclerotic process is crucial for improving our management of hypertriglyceridemia.
That’s why the EAS-LatAm chapter is organizing this webinar.
If you haven’t registered yet, don’t delay – secure your spot today! The webinar will be easily understandable for both Spanish- and English-speaking attendees.
To the registration pageSociety:
EAS Calendar – August-September 2024
From insightful webinars to groundbreaking announcements, this section is your gateway to staying connected and up-to-date with the latest developments within the EAS Society.
August 30 – September 2, ESC Congress 2024, London
September 2 – October 14, Call for Anitschkow Prize 2025 nominations
September 5, LatAm-EAS: Triglyceride-rich lipoproteins as contributors to residual risk
September 13, EAS Competitive Grant: deadline for the applications
September 20, EAS Advanced Course in Rare Lipid Disorders, Slovenia
September 27, EAS Advanced Course in Rare Lipid Disorders, Greece